Tvardi Therapeutics (TVRD) Return on Sales (2013 - 2025)
Tvardi Therapeutics (TVRD) posted Return on Sales of 0.04% for Q1 2025, up 49.39% sequentially from 0.07% in Q4 2024, and up 11.0% YoY from 0.03% in Q1 2024.
Tvardi Therapeutics (TVRD) Return on Sales (2013 - 2025) Analysis & Trends
Tvardi Therapeutics has reported Return on Sales for 13 years, with the latest figure at 0.04% in Q1 2025.
- Quarterly Return on Sales rose 11.0% year-over-year to 0.04% in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.05% (up 3.0% YoY) and the FY2024 annual result came in at 0.1%, down 4.0% from the prior year.
- Return on Sales climbed to 0.04% in Q1 2025 per TVRD's latest filing, from 0.07% in the prior quarter.
- Over five years, Return on Sales peaked at 0.0% in Q2 2021 and troughed at 0.41% in Q4 2021.
- A 5-year average of 0.08% and a median of 0.06% in 2023 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2021 and 2022: Return on Sales plunged 41 bps in 2021, then jumped 31 bps in 2022.
- Over 5 years, Return on Sales stood at 0.41% in 2021, then soared by 76 bps to 0.1% in 2022, then declined by 13 bps to 0.11% in 2023, then surged by 33 bps to 0.07% in 2024, then surged by 49 bps to 0.04% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 0.04%, 0.07%, and 0.04% for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 0.00% |
| 10 | Tvardi Therapeutics | 17.82 Mn | 17.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.07% |
| Sep 30, 2024 | -0.04% |
| Jun 30, 2024 | -0.07% |
| Mar 31, 2024 | -0.15% |
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -0.06% |
| Jun 30, 2023 | -0.05% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | -0.10% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -0.07% |
| Dec 31, 2021 | -0.41% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -0.12% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | -0.02% |
| Jun 30, 2020 | -0.04% |